NextGenWhat is a peptide?
A peptide is a short chain of protein building blocks. The word describes a kind of molecule. It does not tell us whether a particular product is approved, suitable for a person or safe to use.
SHORT ANSWERS / THE CONTEXT
Start with a question.
These NextGen Peptides questions explain the words that can make weight-management research hard to follow. The answers describe compounds and access limits. They do not decide which medicine is appropriate for you.
TARGET STUDY / 03
GLP-1 + GIP + glucagon
01
The questions behind the search.
What does NextGen mean by a generation?
We use generation to count the receptor types a compound acts on. A receptor is a part of a cell that receives a signal. The count is a reading aid, not an official approval category or a ranking.
What do GLP-1 and GIP mean here?
They are names for hormone signals in the body. Hormones carry messages. Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on GIP and GLP-1 receptors. The initials describe the targets, not a personal treatment plan.
What is a triple agonist?
An agonist is a compound that activates a receptor. A triple agonist acts on three receptor types. Retatrutide's targets are GLP-1, GIP and glucagon. Having three targets does not change the fact that retatrutide remains investigational.
Is retatrutide FDA-approved?
No. Retatrutide is investigational and in Phase 3 clinical trials, which are studies in people. It has no approved use and is not available by prescription. This guide does not predict an approval date.
Can I get retatrutide through the links here?
Promise has no retatrutide product. Its links here are for metabolic support, semaglutide or tirzepatide. They are not a route to retatrutide.
Are semaglutide and tirzepatide approved?
FDA-approved products containing those ingredients exist. FDA is short for the U.S. Food and Drug Administration. Approval is specific to a finished medicine. Compounded semaglutide and compounded tirzepatide are not FDA-approved.
What does compounded mean?
It means a medicine is made to order. A compounded medicine is not FDA-approved. The FDA does not review its safety, quality or effectiveness before it is sold. A pharmacy licence is different from product approval.
Why is a research-only label a concern?
Some products are marked “not for human use.” An order does not include a licensed provider reviewing your health. The FDA warns that unapproved products sold with research labels can have unknown quality and may be harmful.
Is NextGen a shop or a medical service?
NextGen is a plain-language guide. It does not sell medicines, arrange prescriptions or assess medical questions. Its links point to a separate service. The link itself is not a health review or an offer of care.
Is Promise prescribing semaglutide and tirzepatide now?
Promise prescribes semaglutide and tirzepatide now through licensed U.S. providers. A provider reviews every request and decides whether to prescribe. Not everyone qualifies. A product page is not a promise of a prescription.
Is the linked route available outside the United States?
Promise is for U.S. patients only. Availability varies by state and by treatment. Reading a page or starting a request does not make care available in another country.
What does LegitScript certification mean?
Promise is LegitScript-certified. This is a private check of business standards, not FDA approval or a rating of medical care. Certification does not replace a provider's review or tell a person which medicine to choose.
02
Reading behind this page.
- FDA: what compounding means
Explains medicines made to order and how they differ from FDA-approved products.
- FDA: risks of compounded medicines
Explains that compounded medicines do not receive FDA approval before they are sold.
- FDA: concerns about unapproved GLP-1 drugs
Covers unapproved products, including retatrutide, sold with research-only labels.
Take the next question to a licensed route.
Promise prescribes semaglutide and tirzepatide now through licensed U.S. providers. A provider reviews every request and decides whether to prescribe. Not everyone qualifies.